thoughts?
The paper, from a research group led by Gilles-Eric Séralini, a molecular biologist at the University of Caen, France, and published in 2012, showed no evidence of fraud or intentional misrepresentation of the data, said a statement from Elsevier, which publishes the journal. But the small number and type of animals used in the study means that no definitive conclusions can be reached. The known high incidence of tumours in the Sprague-Dawley rat cannot be excluded as the cause of the higher mortality and incidence observed in the treated groups, it added.
Todays move came as no surprise. Earlier this month, the journals editor-in-chief, Wallace Hayes, threatened retraction if Séralini refused to withdraw the paper, which is exactly what he announced at a press conference in Brussels this morning. Séralini and his team remained unrepentant, and allege that the retraction derives from the journal's editorial appointment of biologist Richard Goodman, who previously worked for biotechnology giant Monsanto for seven years.
Most Users Ever Online: 698
Currently Online:
48 Guest(s)
Currently Browsing this Page:
1 Guest(s)
Top Posters:
easytapper: 2149
DangerDuke: 2030
groinkick: 1667
PorkChopsMmm: 1515
Gravel Road: 1455
Newest Members:
Forum Stats:
Groups: 1
Forums: 12
Topics: 11482
Posts: 58640
Member Stats:
Guest Posters: 2
Members: 19842
Moderators: 0
Admins: 1
Administrators: K